Earnings Call Insights: Semler Scientific, Inc. (NASDAQ:SMLR) Q4 2024 CEO Doug Murphy-Chutorian highlighted strong ...
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.
Semler Scientific (NASDAQ:SMLR), the device maker best known for its QuantaFlo vascular testing system and recent pivot to bitcoin investing, reported earnings for the quarter on August 4, 2025. The ...
Conestoga Capital Advisors, an asset management company, released its “Micro Cap Strategy” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here. Despite growing by 12.70% net ...
On September 26, the US Department of Justice (DOJ) announced that Semler Scientific Inc., Bard Peripheral Vascular Inc., and affiliated companies agreed to pay nearly $37 million to resolve ...